| Literature DB >> 20939995 |
Patrícia C C Neves1, Richard A Rudersdorf, Ricardo Galler, Myrna C Bonaldo, Marlon Gilsepp Veloso de Santana, Philip A Mudd, Maurício A Martins, Eva G Rakasz, Nancy A Wilson, David I Watkins.
Abstract
The yellow fever 17D (YF-17D) vaccine is one of the most efficacious vaccines developed to date. Interestingly, vaccination with YF-17D induces IFN-γ production early after vaccination (days 5-7) before the development of classical antigen-specific CD8(+) and CD4(+) T cell responses. Here we investigated the cellular source of this early IFN-γ production. At days 5 and 7 post-vaccination activated CD8(+) gamma-delta TCR T cells produced IFN-γ and TNF-α. Activated CD4(+) T cells produced IFN-γ and TNF-α at day 7 post-vaccination. This early IFN-γ production was also induced after vaccination with recombinant YF-17D (rYF-17D), but was not observed after recombinant Adenovirus type 5 (rAd5) vaccination. Early IFN-γ production, therefore, might be an important aspect of yellow fever vaccination.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20939995 PMCID: PMC3179417 DOI: 10.1016/j.vaccine.2010.09.090
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641